$1.13 Billion is the total value of Camber Capital Management LP's 37 reported holdings in Q4 2013. The portfolio turnover from Q3 2013 to Q4 2013 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | New | MERCK & CO. INC NEW | $49,565,000 | – | 990,300 | +100.0% | 4.37% | – |
| UNH | New | UNITEDHEALTH GROUP INC | $48,945,000 | – | 650,000 | +100.0% | 4.32% | – |
| THC | New | TENET HEALTHCARE CORP | $46,332,000 | – | 1,100,000 | +100.0% | 4.09% | – |
| ARIA | New | ARIAD PHARMACEUTICALS INC | $35,805,000 | – | 5,250,000 | +100.0% | 3.16% | – |
| EW | New | EDWARDS LIFESCIENCES CORP | $23,016,000 | – | 350,000 | +100.0% | 2.03% | – |
| CYH | New | COMMUNITY HEALTH SYS INC NEW | $19,635,000 | – | 500,000 | +100.0% | 1.73% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $16,745,000 | – | 8,500,000 | +100.0% | 1.48% | – |
| NXTM | New | NXSTAGE MEDICAL INC | $8,205,000 | – | 820,535 | +100.0% | 0.72% | – |
| GERN | New | GERON CORP | $7,110,000 | – | 1,500,000 | +100.0% | 0.63% | – |
| TRNX | New | TORNIER N V | $4,697,000 | – | 250,000 | +100.0% | 0.41% | – |
| TRGT | New | TARGACEPT INC | $768,000 | – | 185,100 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEVA PHARMACEUTICALS INDS LTD | 34 | Q3 2023 | 9.7% |
| BROOKDALE SR LIVING INC | 32 | Q3 2023 | 5.0% |
| PERRIGO CO PLC | 29 | Q3 2023 | 7.1% |
| TENET HEALTHCARE CORP | 28 | Q3 2023 | 8.5% |
| NEKTAR THERAPEUTICS | 28 | Q1 2022 | 9.8% |
| UNIVERSAL HLTH SVCS INC | 25 | Q3 2023 | 9.9% |
| MYRIAD GENETICS INC | 24 | Q3 2023 | 5.0% |
| SAREPTA THERAPEUTICS INC | 23 | Q3 2023 | 6.0% |
| MYLAN NV | 21 | Q3 2020 | 10.1% |
| AMAG PHARMACEUTICALS INC | 21 | Q3 2020 | 4.0% |
View Camber Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC | February 02, 2023 | ? | ? |
| Solid Biosciences Inc. | December 12, 2022 | ? | ? |
| AVROBIO, Inc. | February 14, 2022 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 14, 2022 | ? | ? |
| AMAG PHARMACEUTICALS, INC. | February 16, 2021 | ? | ? |
| Atara Biotherapeutics, Inc. | February 16, 2021 | ? | ? |
| Change Healthcare Inc. | February 16, 2021 | ? | ? |
| GLYCOMIMETICS INC | February 16, 2021 | ? | ? |
| Clovis Oncology, Inc. | February 14, 2020 | ? | ? |
| Cyclerion Therapeutics, Inc. | February 14, 2020 | ? | ? |
View Camber Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-30 |
| 13F-HR | 2023-08-14 |
View Camber Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.